Last reviewed · How we verify

NCT04876989

The Comparison of Sympathetic Blockade of Stellate Ganglion Block and Thoracic Paravertebral Block

Completed NA Last updated 17 October 2023
What this trial tests

NA trial testing US-SGB in Complex Regional Pain Syndromes in 69 participants. Completed in 16 January 2023.

Timeline
21 July 2021
Primary endpoint
19 December 2022
16 January 2023

Quick facts

Lead sponsorSeoul National University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment69
Start date21 July 2021
Primary completion19 December 2022
Estimated completion16 January 2023
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University

Who can join

Adults 19 to 85, any sex, with Complex Regional Pain Syndromes or Postherpetic Neuralgia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate the effect of ultrasound-guided thoracic paravertebral block (TPVB) when performing sympathetic block for upper limb pain control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Complex Regional Pain Syndromes

Currently open trials in the same condition.

Other Seoul National University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04876989.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing